BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21046128)

  • 21. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
    Park HS; Nam KY; Kim JY
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
    Chew SK; Levy J; Rogers S; Lim LL
    Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two cases of Vogt-Koyanagi-Harada disease presenting shallow anterior chamber].
    Takemoto D; Ijiri S; Shimizu M; Higashide T; Sugiyama K
    Nippon Ganka Gakkai Zasshi; 2015 May; 119(5):354-62. PubMed ID: 26062392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
    Bacsal K; Wen DS; Chee SP
    Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
    Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
    Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vogt-Koyanagi-Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia.
    Guayacán CL; Galindo-Mendez B; de-la-Torre A
    Ocul Immunol Inflamm; 2018; 26(7):1123-1127. PubMed ID: 28910557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
    Yang HK; Park KH; Kim JS; Hwang JM
    Can J Ophthalmol; 2014 Apr; 49(2):e54-6. PubMed ID: 24767242
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravascular lymphoma mimicking a Vogt-Koyanagi-Harada disease.
    Angioi K; Bodaghi B; Kaminsky P; Mokhtari K; Lubetzki C; LeHoang P
    Ocul Immunol Inflamm; 2011 Apr; 19(2):132-4. PubMed ID: 21428755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N; Morisod L; Herbort CP
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease.
    Gupta V; Gupta A; Gupta P; Sharma A
    Am J Ophthalmol; 2009 Jan; 147(1):148-153.e2. PubMed ID: 18834577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanin-laden macrophages in the CSF to diagnose Vogt-Koyanagi-Harada simulating ocular syphilis.
    Kim LA; Khurana RN; Parikh JG; Rao NA
    Ocul Immunol Inflamm; 2008; 16(1):59-61. PubMed ID: 18379946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease.
    Errera MH; Levinson RD; Fardeau C; Thomas D; Cohen D; Navarro A; Héron E; Paques M; Pavesio C; Sahel JA; Westcott MC; Gaudric A; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2015 Sep; 93(6):e509-10. PubMed ID: 25604241
    [No Abstract]   [Full Text] [Related]  

  • 35. Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study.
    Ingolotti M; Schlaen BA; Roig Melo-Granados EA; Ruiz García H; Aguilera Partida JA
    Am J Case Rep; 2019 Mar; 20():300-305. PubMed ID: 30842390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
    Bordaberry MF
    Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.
    Yang HK; Yu HG
    Korean J Ophthalmol; 2009 Dec; 23(4):325-8. PubMed ID: 20046700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autofluorescence findings in Vogt-Koyanagi-Harada disease.
    Ayata A; Dogru S; Senol MG; Unal M; Ersanli D; Bilge AH
    Eur J Ophthalmol; 2009; 19(6):1094-7. PubMed ID: 19882556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab.
    Su E; Oza VS; Latkany P
    J Formos Med Assoc; 2019 May; 118(5):945-950. PubMed ID: 30616991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.